Tuesday, January 31, 2023

Tag: SCOTUS

Malignant Do-Gooderism: The Tragedies of Allopathic Psychiatry

4
My personal struggle to stop my friend’s court-ordered psychiatric deterioration has reached the US Supreme Court.

SCOTUS Declines Risperdal Appeal, J&J to Pay $124 M

10
On Monday, the US Supreme Court declined to hear Johnson and Johnson’s final appeal, forcing the company to pay $124 million for the deceptive marketing of the antipsychotic Risperdal. In 2011, South Carolina ordered the company to pay $327 million for pursuing “profits-at-all-costs” in its efforts to persuade doctors to prescribe their drug, but the fine was lowered to $136 million last year. The company had hoped to argue that the remaining penalties constituted an “excessive fine” and was supported by PhRMA, the Washington Legal Foundation, the Cato Institute and the Chamber of Commerce.